Cargando…
Quality of Life and Hemodynamic Effects of Switching From Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort Study
BACKGROUND: Recent randomized clinical trials have demonstrated beneficial effects of hemodiafiltration (HDF) compared with hemodialysis (HD) on mortality and hemodynamic stability. Data on quality of life in HDF compared with HD is limited. OBJECTIVE: This study aimed to determine whether patients...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600559/ https://www.ncbi.nlm.nih.gov/pubmed/34804556 http://dx.doi.org/10.1177/20543581211057717 |
_version_ | 1784601178218168320 |
---|---|
author | Ethier, Isabelle Nevis, Immaculate Suri, Rita S. |
author_facet | Ethier, Isabelle Nevis, Immaculate Suri, Rita S. |
author_sort | Ethier, Isabelle |
collection | PubMed |
description | BACKGROUND: Recent randomized clinical trials have demonstrated beneficial effects of hemodiafiltration (HDF) compared with hemodialysis (HD) on mortality and hemodynamic stability. Data on quality of life in HDF compared with HD is limited. OBJECTIVE: This study aimed to determine whether patients receiving HD experience improvements in quality of life, hemodynamic and laboratory parameters after switching to HDF. DESIGN: Observational controlled cohort study. SETTING & PATIENTS: Adult patients receiving maintenance dialysis were followed for 3 months both before and after transfer to a new unit, where they received HDF. Prior to transfer, control patients were already treated by HDF. METHODS: Quality of life at baseline and follow-up was measured using the validated minutes to recovery (MR) question. Dialysis data were collected for 3 consecutive sessions monthly; laboratory values were collected monthly. Wilcoxon signed rank test and repeated measures analysis of covariance were used to evaluate pre/post transfer changes and quantile regression to identify predictors of change in recovery time. RESULTS: Of 227 patients, 82 died, were transplanted, were hospitalized or did not transfer, leaving 123 subjects and 22 controls for analysis. MR did not improve with switching to HDF, although patients with MR > 60 min before transfer experienced a significant decrease in their MR, compared with controls. There was no improvement in intradialytic hypotension with HDF. There were no differences in laboratory values before vs after switch. LIMITATIONS: Nonrandomized single-center study, including only small numbers of patients and covering a short follow-up period; hemodynamic values only evaluated over 1 week per month; residual kidney function not recorded. CONCLUSIONS: In this Canadian experience of HDF, patients remained stable with respect to several laboratory and dialysis related parameters. Switch to HDF was associated with substantially reduced recovery time in patients with MR > 60 minutes at baseline. |
format | Online Article Text |
id | pubmed-8600559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-86005592021-11-19 Quality of Life and Hemodynamic Effects of Switching From Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort Study Ethier, Isabelle Nevis, Immaculate Suri, Rita S. Can J Kidney Health Dis Original Clinical Research Quantitative BACKGROUND: Recent randomized clinical trials have demonstrated beneficial effects of hemodiafiltration (HDF) compared with hemodialysis (HD) on mortality and hemodynamic stability. Data on quality of life in HDF compared with HD is limited. OBJECTIVE: This study aimed to determine whether patients receiving HD experience improvements in quality of life, hemodynamic and laboratory parameters after switching to HDF. DESIGN: Observational controlled cohort study. SETTING & PATIENTS: Adult patients receiving maintenance dialysis were followed for 3 months both before and after transfer to a new unit, where they received HDF. Prior to transfer, control patients were already treated by HDF. METHODS: Quality of life at baseline and follow-up was measured using the validated minutes to recovery (MR) question. Dialysis data were collected for 3 consecutive sessions monthly; laboratory values were collected monthly. Wilcoxon signed rank test and repeated measures analysis of covariance were used to evaluate pre/post transfer changes and quantile regression to identify predictors of change in recovery time. RESULTS: Of 227 patients, 82 died, were transplanted, were hospitalized or did not transfer, leaving 123 subjects and 22 controls for analysis. MR did not improve with switching to HDF, although patients with MR > 60 min before transfer experienced a significant decrease in their MR, compared with controls. There was no improvement in intradialytic hypotension with HDF. There were no differences in laboratory values before vs after switch. LIMITATIONS: Nonrandomized single-center study, including only small numbers of patients and covering a short follow-up period; hemodynamic values only evaluated over 1 week per month; residual kidney function not recorded. CONCLUSIONS: In this Canadian experience of HDF, patients remained stable with respect to several laboratory and dialysis related parameters. Switch to HDF was associated with substantially reduced recovery time in patients with MR > 60 minutes at baseline. SAGE Publications 2021-11-15 /pmc/articles/PMC8600559/ /pubmed/34804556 http://dx.doi.org/10.1177/20543581211057717 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Clinical Research Quantitative Ethier, Isabelle Nevis, Immaculate Suri, Rita S. Quality of Life and Hemodynamic Effects of Switching From Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort Study |
title | Quality of Life and Hemodynamic Effects of Switching From
Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort
Study |
title_full | Quality of Life and Hemodynamic Effects of Switching From
Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort
Study |
title_fullStr | Quality of Life and Hemodynamic Effects of Switching From
Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort
Study |
title_full_unstemmed | Quality of Life and Hemodynamic Effects of Switching From
Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort
Study |
title_short | Quality of Life and Hemodynamic Effects of Switching From
Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort
Study |
title_sort | quality of life and hemodynamic effects of switching from
hemodialysis to hemodiafiltration: a canadian controlled cohort
study |
topic | Original Clinical Research Quantitative |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600559/ https://www.ncbi.nlm.nih.gov/pubmed/34804556 http://dx.doi.org/10.1177/20543581211057717 |
work_keys_str_mv | AT ethierisabelle qualityoflifeandhemodynamiceffectsofswitchingfromhemodialysistohemodiafiltrationacanadiancontrolledcohortstudy AT nevisimmaculate qualityoflifeandhemodynamiceffectsofswitchingfromhemodialysistohemodiafiltrationacanadiancontrolledcohortstudy AT suriritas qualityoflifeandhemodynamiceffectsofswitchingfromhemodialysistohemodiafiltrationacanadiancontrolledcohortstudy |